Prognostic significance of c-ABL methylation in chronic myelogenous leukemia:: Still an open question

被引：8

作者：

Asimakopoulos, FA ^{[1
]}

Shteper, PJ ^{[1
]}

Fibach, E ^{[1
]}

Rachmilewitz, E ^{[1
]}

Ben-Neriah, Y ^{[1
]}

Ben-Yehuda, D ^{[1
]}

机构：

[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, Hadassah Univ Hosp Ein Karem, IL-91010 Jerusalem, Israel

来源：

BLOOD | 1999年 / 94卷 / 03期

关键词：

D O I：

10.1182/blood.V94.3.1141.415a35d_1141_1142

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1141 / 1141

页数：1

共 7 条

[1]

ASIMAKOPOULOS FA, IN PRESS BLOOD

[2] Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia [J].

BenYehuda, D ;

Krichevsky, S ;

Rachmilewitz, EA ;

Avraham, A ;

Palumbo, GA ;

Frassoni, F ;

Sahar, D ;

Rosenbaum, H ;

Paltiel, O ;

Zion, M ;

Ben-Neriah, Y .

BLOOD, 1997, 90 (12) :4918-4923

[3] Antagonistic effects of ABL and BCRABL proteins on proliferation and the response to genotoxic stress in normal and leukemic myeloid cells [J].

Guo, XYD ;

Fontana, J ;

Kufe, D ;

Deisseroth, A .

LEUKEMIA & LYMPHOMA, 1998, 30 (3-4) :225-235

[4]

Issa J. P., 1997, Blood, V90, p196A

[5] Methylation of the ABL1 promoter in chronic myelogenous leukemia:: Lack of prognostic significance [J].

Issa, JPJ ;

Kantarjian, H ;

Mohan, A ;

O'Brien, S ;

Cortes, J ;

Pierce, S ;

Talpaz, M .

BLOOD, 1999, 93 (06) :2075-2080

[6]

Willer A., 1997, Blood, V90, p196A

[7] PROGRESSIVE DE-NOVO DNA METHYLATION AT THE BCR-ABL LOCUS IN THE COURSE OF CHRONIC MYELOGENOUS LEUKEMIA [J].

ZION, M ;

BENYEHUDA, D ;

AVRAHAM, A ;

COHEN, O ;

WETZLER, M ;

MELLOUL, D ;

BEN-NERIAH, Y .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) :10722-10726

← 1 →